![]() |
|||
|
|
| UPDATE: February 2003 | MW: 423.45 | MF: C19H18N3O5S•Na |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | rat
lethal dose (50 percent kill): 1,500 mg/kg
|
N/R
|
ARZNAD 15,322,1965
|
intravenous | human
lowest published toxic dose: 1,200 mg/kg/7 day
|
Liver: Liver function tests impaired
|
AIMDAP 138,915,1978
|
intravenous | mouse
lethal dose (50 percent kill): 1,399 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea
FATOAO 31,232,1968
|
intravenous | mouse
lethal dose (50 percent kill): 1.5 gm/kg
|
N/R
|
VCVPS* -,379,1998
|
intravenous | rat
lethal dose (50 percent kill): 2,150 µg/kg
|
N/R
|
NIIRDN 6,147,1982
|
oral | cat
lowest published lethal dose: >750 mg/kg
|
N/R
|
ARZNAD 15,322,1965
|
oral | mouse
lethal dose (50 percent kill): >10 gm/kg
|
N/R
|
NIIRDN 6,147,1982
|
oral | rat
lethal dose (50 percent kill): 10 gm/kg
|
N/R
|
VCVPS* -,379,1998
|
oral | woman
lowest published toxic dose: 4,560 mg/kg/11 week- intermittent
|
Liver: Other changes | Musculoskeletal: Other changes
RMMJAK 62,34,1965
|
subcutaneous | mouse
lethal dose (50 percent kill): 2,600 µg/kg
|
N/R
|
NIIRDN 6,147,1982
|
subcutaneous | rat
lethal dose (50 percent kill): 3,900 µg/kg
|
N/R
|
NIIRDN 6,147,1982
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
unreported route | human
lowest published toxic dose: 0.28 gm/kg/7 day- intermittent
|
Skin: After systemic exposure: Dermatitis, allergic | Blood: Luekopenia Nutritional and Gross Metabolic: Body temperature increase
VCVPS* -,379,1998
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X4485 |
Number of Industries 1; Total Number of Facilities 151; Number of Occupations 6; Total Number of Employees Exposed 3,615; Total Number of Female Employees Exposed 2,410 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
AIMDAP
|
Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908-
|
ARZNAD
|
Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960
Aulendorf, Fed. Rep. Ger.) V.1- 1951-
|
FATOAO
|
Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939-
|
NIIRDN
|
Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan)
|
RMMJAK
|
Rocky Mountain Medical Journal. (Denver, Co) V.35-76, 1938-79.
|
VCVPS*
|
"Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances.
Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998.
|
| |